The treatment of diffuse cutaneous systemic sclerosis with autologous hemopoietic stem cells transplantation (HSCT): our experience on 2 cases
Objectives: Autologous hematopoietic stem cell transplantation (HSCT) is a treatment option which may be considered for severe diffuse cutaneous systemic sclerosis (dcSSc) patients not responding to cyclophophamide (CY). We present two cases of dcSSc not responding to CY >10 g who were successful...
Main Authors: | A. Tyndall, S. Urbani, S. Guidi, A. Bosi, S. Guiducci, F. Pagliai, R. Saccardi, I. Miniati, M. Matucci Cerinic |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2011-09-01
|
Series: | Reumatismo |
Online Access: | http://www.reumatismo.org/index.php/reuma/article/view/230 |
Similar Items
-
Longitudinal Changes of Ocular Surface Microbiome in Patients Undergoing Hemopoietic Stem Cell Transplant (HSCT)
by: Suzanne Clougher, et al.
Published: (2023-12-01) -
Vasculogenesis and angiogenesis: vascular damage in systemic sclerosis
by: M. Matucci Cerinic, et al.
Published: (2011-06-01) -
Autologous peripheral hemopoietic cell transplantation in the treatment of AL-amyloidosis
by: Anna Gennad'evna Smirnova, et al.
Published: (2010-10-01) -
Impact of autologous HSCT on the quality of life and fatigue in patients with relapsing multiple sclerosis
by: N. Giedraitiene, et al.
Published: (2022-09-01) -
Primary Localized Cutaneous Nodular Amyloidosis and Limited Cutaneous Systemic Sclerosis: Additional Cases with Dermatoscopic and Histopathological Correlation of Amyloid Deposition
by: Laura Atzori, et al.
Published: (2021-07-01)